Clinical Trials Sponsored by Pieter Muntendam

Total 1194 results

Pierre Fabre Dermatology

Withdrawn

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Healthy Volunteers

United Kingdom
University of Exeter

Completed

Singing for People With Aphasia (SPA)

Aphasia

United Kingdom
Ritter Pharmaceuticals, Inc.

Completed

Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects (RP)

Lactose Intolerance

United States
University of Exeter

Completed

Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial

Bipolar Disorder

United Kingdom
Ritter Pharmaceuticals, Inc.

Completed

Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance

Lactose Intolerance

United States
Pierre Fabre Dermatology

Completed

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Infantile Hemangioma

Germany, United States, France, Spain, Peru, Australia, Lithuania, Italy, Canada, Czech Republic, Hungary, Mexico, New Zealand, Poland, Romania, Russian Federation
Pierre Fabre Medicament

Completed

Nicotine Patch - Bioequivalence Study

Healthy Smokers

France
Pierre Fabre Medicament

Completed

Emollients in the Management of Atopic Dermatitis

Atopic Dermatitis

France, Romania, Estonia, Poland, Lithuania
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
Pierre Fabre Medicament

Completed

FMS European Long-Term Study

Fibromyalgia Syndrome

Spain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden
Pierre Fabre Medicament

Completed

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

Atopic Dermatitis

Estonia, France, Lithuania, Poland, Romania
University of Exeter

Recruiting

EvolvRehab for Telerehabilitation

Stroke

United Kingdom
Pierre Fabre Medicament

Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Melanoma | Non-small Cell Lung Cancer | Solid Tumor, Adult

United States, Australia, France, Spain, Taiwan, Korea, Republic of, China, Netherlands
University of Exeter

Active, not recruiting

The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults. (PIE)

Aging | Muscle Atrophy | Energy Malnutrition Protein

United Kingdom
University of Exeter

Active, not recruiting

GP Response to Decontextualised Risk

Diagnoses Disease

United Kingdom
University of Exeter

Completed

The Muscle Protein Synthetic Response of Algal and Fungal Protein (SCAM)

Muscle Metabolism

United Kingdom
University of Exeter

Completed

Energy Balance in Extreme Environments: Finding the EI Limit (StOMPE)

Energy Expenditure | Energy Intake | Atrophy, Muscular

United Kingdom
Pierre Fabre Medicament

Withdrawn

Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Hepatic Impairment | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

Spain, Czechia, Italy
Pierre Fabre Medicament

Completed

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors (OCEANI)

Melanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLC

China
University of Exeter

Withdrawn

Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis (2d-BR)

Healthy
University of Exeter

Active, not recruiting

Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle? (ARM)

Healthy

United Kingdom
University of Exeter

Completed

Supplemental Protein And Resistance Training Adaptations (SPARTA)

Hypertrophy

United Kingdom
University of Exeter

Completed

Timecourse of Immobilization Experiment (TIME)

Muscular Atrophy

United Kingdom
University of Exeter

Completed

The Effect of Dietary Nitrate on Blood Pressure, Insulin Sensitivity, and Vascular Function in Type 2 Diabetes

Hypertension | Diabetes

United Kingdom
Pierre Fabre Medicament

Terminated

A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer (VICTORIA)

Advanced Breast Cancer
University of Exeter

Completed

The Impact of Enteral Versus Oral Protein Feeding on Muscle Protein Synthesis in Healthy Young Males and Females

Healthy

United Kingdom
University of Exeter

Completed

Identifying Physical Activity Intensity Through Accelerometry in Heart Failure

Heart Failure

United Kingdom
University of Exeter

Completed

The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise. (SPADE)

Healthy

United Kingdom
Porter Adventist Hospital

Terminated

Donepezil Memory Preservation Post ECT

Memory Impairment

United States
University of Exeter

Completed

Bed Rest, Inactivity and Early Responses (BIER)

Metabolic Responses to Inactivity

United Kingdom
Pierre Fabre Medicament

Completed

F17464 in Acute Schizophrenia Trial (FAST)

Schizophrenia

Romania, Russian Federation, Hungary, Latvia, France
Pierre Fabre Medicament

Completed

Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema

Chronic Venous Insufficiency (CVI)

France
Pierre Fabre Medicament

Completed

Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

Subject

France
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Pierre Fabre Medicament

Completed

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

Alveolar Osteitis

France, Lithuania, Latvia, Estonia
Pierre Fabre Medicament

Completed

Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.

Open Cracked Heel in Diabetic Patients With Polyneuropathy

France, Belgium
Pierre Fabre Medicament

Completed

Assessment of V0018 1.5 mg Effect on Craving

Smoking

France
Pierre Fabre Medicament

Completed

Bronchodilator Properties and Safety in Asthma

Asthma

Germany
Pierre Fabre Medicament

Completed

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

Iron Deficiency Anemia

Romania
Pierre Fabre Medicament

Completed

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Drug-induced Xerostomia

Germany
Pierre Fabre Medicament

Completed

A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

Fibromyalgia Syndrome

Spain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden, Denmark, Poland, United Kingdom
Pierre Fabre Medicament

Completed

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

Fibromyalgia Syndrome

Switzerland
Pierre Fabre Medicament

Completed

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

Healthy Volunteers

Belgium
Pierre Fabre Medicament

Completed

Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

Lung Cancer

France
Pierre Fabre Medicament

Withdrawn

Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis (VESTA)

Knee Osteoarthritis
Pierre Fabre Medicament

Completed

Brain Imaging Study of F17464

Healthy Volunteers

United States
Pierre Fabre Medicament

Completed

Nicotine Patch Safety Study

Smokers

France
Pierre Fabre Medicament

Completed

Acute Sore Throat Pain Study

Acute Sore Throat Pain

United Kingdom, France, Germany
Ritter Pharmaceuticals, Inc.

Completed

Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

Lactose Intolerance

United States
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment (BERING-CRC)

Metastatic Colorectal Carcinoma

Austria, Germany

Clinical Trials Sponsored by Pieter Muntendam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations